Ulisse Biomed SpA (MIL:UBM) ROE % Adjusted to Book Value : -24.52% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ulisse Biomed SpA ROE % Adjusted to Book Value?

Ulisse Biomed SpA's ROE % for the quarter that ended in Jun. 2024 was -22.56%. Ulisse Biomed SpA's PB Ratio for the quarter that ended in Jun. 2024 was 0.92. Ulisse Biomed SpA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -24.52%.

Ulisse Biomed SpA ROE % Adjusted to Book Value Historical Data

The historical data trend for Ulisse Biomed SpA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ulisse Biomed SpA ROE % Adjusted to Book Value Chart

Ulisse Biomed SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-3.71

-14.36

-11.58

Ulisse Biomed SpA Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial					-8.06	-17.75	-34.10	8.29	-24.52

Competitive Comparison of Ulisse Biomed SpA's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Ulisse Biomed SpA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ulisse Biomed SpA's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ulisse Biomed SpA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ulisse Biomed SpA's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Ulisse Biomed SpA ROE % Adjusted to Book Value Calculation

Ulisse Biomed SpA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-13.89%	/	1.20
	=	-11.58%

Ulisse Biomed SpA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-22.56%	/	0.92
	=	-24.52%

Ulisse Biomed SpA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ulisse Biomed SpA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ulisse Biomed SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ulisse Biomed SpA (MIL:UBM) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Area Science Park - SS14 km.163, 5, Basovizza, ITA, 34149

Website

https://www.ulissebiomed.com

Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.

Ulisse Biomed SpA Headlines

No Headlines